CONMED 将来の成長

NYSE:CNMD - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	1,499	169	190	186	7
12/31/2025	1,399	139	179	158	8
12/31/2024	1,302	118	137	129	8
9/30/2024	1,288	132	166	180	N/A
6/30/2024	1,276	99	159	175	N/A
3/31/2024	1,262	82	142	158	N/A
12/31/2023	1,245	64	106	125	N/A
9/30/2023	1,169	58	38	57	N/A
6/30/2023	1,139	88	16	37	N/A
3/31/2023	1,099	-94	7	29	N/A
12/31/2022	1,045	-81	12	33	N/A
9/30/2022	1,069	-83	59	79	N/A
6/30/2022	1,042	-114	56	74	N/A
3/31/2022	1,020	68	74	90	N/A
12/31/2021	1,011	63	97	112	N/A
9/30/2021	989	62	83	98	N/A
6/30/2021	979	54	99	112	N/A
3/31/2021	881	13	70	83	N/A
12/31/2020	862	10	52	65	N/A
9/30/2020	874	0	69	85	N/A
6/30/2020	870	0	69	87	N/A
3/31/2020	951	34	84	103	N/A
12/31/2019	955	29	75	95	N/A
9/30/2019	933	29	60	79	N/A
6/30/2019	901	28	28	47	N/A
3/31/2019	876	31	29	46	N/A
12/31/2018	860	41	58	75	N/A
9/30/2018	840	72	55	71	N/A
6/30/2018	828	73	N/A	80	N/A
3/31/2018	812	71	N/A	75	N/A
12/31/2017	796	55	N/A	66	N/A
9/30/2017	778	15	N/A	58	N/A
6/30/2017	773	16	N/A	70	N/A
3/31/2017	769	12	N/A	72	N/A
12/31/2016	764	15	N/A	40	N/A
9/30/2016	750	16	N/A	36	N/A
6/30/2016	735	17	N/A	24	N/A
3/31/2016	722	22	N/A	17	N/A
12/31/2015	719	30	N/A	51	N/A
9/30/2015	723	34	N/A	64	N/A
6/30/2015	729	27	N/A	65	N/A
3/31/2015	736	30	N/A	63	N/A
12/31/2014	740	32	N/A	65	N/A
9/30/2014	747	31	N/A	67	N/A
6/30/2014	750	35	N/A	83	N/A
3/31/2014	753	34	N/A	93	N/A
12/31/2013	763	36	N/A	81	N/A

アナリストによる今後の成長予測

収入対貯蓄率: CNMDの予測収益成長率 (年間13.8% ) は貯蓄率 ( 2.6% ) を上回っています。

収益対市場: CNMDの収益 ( 13.8% ) US市場 ( 15.4% ) よりも低い成長が予測されています。

高成長収益: CNMDの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: CNMDの収益 ( 6.7% ) US市場 ( 9% ) よりも低い成長が予測されています。

高い収益成長: CNMDの収益 ( 6.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: CNMDの自己資本利益率は、3年後には低くなると予測されています ( 14.9 %)。

CONMED 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Consensus EPS estimates increase by 10%, revenue downgraded

Price target decreased by 8.8% to US$84.25

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Recent updates

President exercised options and sold US$570k worth of stock

CONMED's (NYSE:CNMD) Earnings Are Weaker Than They Seem

Investor sentiment improves as stock rises 16%

New minor risk - Earnings quality

Earnings Beat: CONMED Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

New minor risk - Earnings quality

CONMED Corporation Announces Chief Executive Officer Changes

CONMED Corporation Announces Chief Executive Officer Changes

CONMED Corporation to Report Q3, 2024 Results on Oct 30, 2024

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$71.92?

Why We're Not Concerned About CONMED Corporation's (NYSE:CNMD) Share Price

Upcoming dividend of US$0.20 per share

CONMED Corporation Announces Termination of Stanley W. (Bill) Peters as President, Advanced Surgical & Advanced Endoscopic Technologies, Effective August 31, 2024

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

Second quarter dividend of US$0.20 announced

Consensus EPS estimates increase by 10%, revenue downgraded

Price target decreased by 8.8% to US$84.25

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

CONMED Corporation's (NYSE:CNMD) Intrinsic Value Is Potentially 97% Above Its Share Price

CONMED Corporation to Report Q2, 2024 Results on Jul 31, 2024

AirSeal Concerns Have Let Too Much Air Out Of Conmed's Valuation

Insider notifies of intention to sell stock

Upcoming dividend of US$0.20 per share

There Is A Reason CONMED Corporation's (NYSE:CNMD) Price Is Undemanding

First quarter dividend of US$0.20 announced

CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

CONMED Corporation Revises Earnings Guidance for the Full Year 2024

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

CONMED Corporation, Annual General Meeting, May 22, 2024

CONMED Corporation to Report Q1, 2024 Results on Apr 24, 2024

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Insider exercised options and sold US$721k worth of stock

Upcoming dividend of US$0.20 per share

CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Full year 2023 earnings: EPS misses analyst expectations

CONMED Corporation Provides Financial Guidance for the Full Year 2024

Investor sentiment deteriorates as stock falls 17%

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 11%

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Price target decreased by 9.5% to US$123

Third quarter 2023 earnings: EPS misses analyst expectations

CONMED Corporation Updates Third Quarter Guidance for 2023

CONMED Corporation to Report Q3, 2023 Results on Oct 25, 2023

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Upcoming dividend of US$0.20 per share at 0.7% yield

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

CONMED Corporation Revises Earnings Guidance for the Full Year 2023

CONMED Corporation to Report Q2, 2023 Results on Jul 26, 2023

Insider notifies of intention to sell stock

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Upcoming dividend of US$0.20 per share at 0.6% yield

CONMED Corporation Announces Quarterly Cash Dividend, Payable on July 5, 2023

Insider notifies of intention to sell stock

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Insider recently sold US$166k worth of stock

Price target increased by 13% to US$126

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind